Hippocratic AI, a leading developer of safety-driven generative AI solutions for healthcare, has raised $126 million in its Series C funding round, valuing the company at $3.5 billion. The latest round brings its total capital raised to $404 million.
The Series C round was spearheaded by Avenir Growth, known for backing transformative companies in the generative AI space. It also drew support from both new and returning investors, including CapitalG (Google’s growth arm), General Catalyst, Andreessen Horowitz (a16z), Kleiner Perkins, Premji Invest, Universal Health Services, Cincinnati Children’s Hospital Medical Center, WellSpan Health, along with individual investors such as John Doerr and Rick Klausner.
In the 15 months since launching commercially, the company has built collaborations with more than 50 major healthcare systems, insurers, and pharmaceutical organisations across six countries. It has developed over a thousand clinical applications and facilitated more than 115 million patient interactions without a single safety incident. The momentum continues to grow as healthcare providers increasingly rely on scalable and safety-assured generative AI tools to expand access and efficiency in care delivery.
READ: Nvidia backed Emerald AI secures $42.5M to power-flexible infrastructure (
Reflecting on this, raising capital, Hemant Taneja, CEO of General Catalyst, which co-created Hippocratic AI, wrote in his LinkedIn post, “Congratulations to Munjal and the Hippocratic AI team for raising $126MM to accelerate world wide adoption of AI healthcare agents.”
Taneja further added, “Munjal and I co-founded Hippocratic 2.5 years ago to develop an AI workforce for healthcare. I’m simply amazed at the progress the company has made in such a short period — from partnering with leading health systems worldwide to build a system of LLMs that is safe, intelligent and empathetic, to serving millions of patients with an agentic workforce that’s very affordable.”
“It gives me great pride when I think forward to the potential of driving abundance with Hippocratic’s agentic workforce as we go down the path of health assurance — proactive, affordable and accessible care for everyone.” Taneja shared. “I’m also very grateful for the work that General Catalyst’s Alexandre Momeni has done in bringing this important company to this point.”
The company’s growing network of over 50 major healthcare partners across provider, insurer, and life sciences sectors reflects strong confidence in its secure and scalable AI solutions. Its collaborators include globally recognised names such as Cleveland Clinic, Northwestern Medicine, Ochsner Health, Moffitt Cancer Center, University Hospitals, Guy’s & St Thomas’ NHS Trust, Advocate Health, Cincinnati Children’s Hospital, Sanford Health, OhioHealth, Memorial Hermann, and Sheba Medical Center, among others.
READ: Startup founded by former DeepMind researchers Reflection AI raises $2 billion (
Hippocratic AI is also engaged with several leading payors, including more than half of the top 10 insurers, and multiple top pharmaceutical companies, underscoring its expanding influence across the global healthcare ecosystem.
The new funding will help Hippocratic AI scale its global reach and enhance its product offerings. The company plans to expand customer deployments across markets, advance its Polaris Safety Constellation Architecture, and invest further in product innovation. It also intends to explore strategic acquisitions to strengthen its technology portfolio and extend its impact across the broader healthcare landscape.
Hippocratic AI has built what it calls the safest generative AI agents designed specifically for healthcare. The company envisions a future where such technology helps make quality care accessible to everyone. Its focus remains on developing non-diagnostic, patient-facing clinical agents that support but never replace medical professionals. These AI tools are not permitted to diagnose conditions or prescribe treatments.
To date, Hippocratic AI has received a total of $404 million from prominent investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, and NVIDIA’s NVentures.